NCT01480622View on ClinicalTrials.gov

Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

December 5, 2011

Primary Completion Date

December 30, 2011

Study Completion Date

December 30, 2011

Conditions

Hepatitis B, Chronic

Interventions

DRUG

TDF tablets

"White, almond-shaped, film-coated tablets, one side with the markings GILEAD and 4331"

Trial Locations (1)

200030

GSK Investigational Site, Shanghai

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY